Evidence map›Paper›PMID 41653022›Full record

ArticleFuture oncology (London, England)2026

Consumer acceptability of a cancer registry-driven familial cancer testing pathway: a qualitative study using the Theoretical Framework of Acceptability.

Zoe Fehlberg, Sue M Evans, Maria Bechelli, Sanne Peters, Anu Abraham, Michael Bogwitz, Ainsley Campbell, Halianna Van Niel, Alison H Trainer, Stephanie Best

Abstract read
In one paragraph

Article in Future oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zoe FehlbergSchool of Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.
Sue M EvansVictorian Cancer Registry, Cancer Council Victoria, Melbourne, VIC, Australia.
Maria BechelliVictorian Cancer Registry, Cancer Council Victoria, Melbourne, VIC, Australia.
Sanne PetersSchool of Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.
Anu AbrahamVictorian Cancer Registry, Cancer Council Victoria, Melbourne, VIC, Australia.
Michael BogwitzParkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Ainsley CampbellAustin Clinical Genetics Unit, Austin Hospital, Melbourne, VIC, Australia.
Halianna Van NielParkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Alison H TrainerParkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Stephanie BestSchool of Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFamilial cancer test referral rates for rare tumors are suboptimal and follow a social gradient; while cancer registries are legally mandated to collect comprehensive clinical pathological data which could be used to inform clinical practice. We aimed to investigate consumer acceptability of and preferred approach for a cancer registry-driven familial cancer testing notification pathway.

methodsA qualitative study using semi-structured interviews informed by the Theoretical Framework of Acceptability was conducted.

resultsNineteen individuals recently disclosed to the Victorian Cancer Registry diagnosed with a cancer meeting local familial cancer testing criteria were interviewed. Participants supported being notified directly by the cancer registry to inform them about familial cancer testing, as they welcomed using existing health data in new ways to optimize health care. Key considerations included the timing, tone, language, information provided in the registry communication, and minimizing the onus on the patient. Assuring data security and verifying the legitimacy of the registry were raised.

conclusionIndividuals diagnosed with cancer found the service model acceptable. Participants preferred either to action the findings independently, with supporting resources, or permit the cancer registry to directly inform treating clinicians. Ongoing and consumer-informed work is required to develop processes and resources including digital options.

Indexed as

Early Detection of CancerGenetic TestingNeoplasmsPatient Acceptance of Health CareRegistriesAdultAgedFemaleHumansMaleMiddle AgedQualitative ResearchReferral and Consultationcancer registryconsumer acceptabilityFamilial cancer testingimplementation sciencequalitative

Identifiers

PMID41653022
PMCPMC13048603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.